GlassScriptPhysician profile
Ramit K Sharma
NPI 1659374593
$64,542.70
in general payments reported to CMS, 2019-2025
46 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $11K · 2021: $9,760 · 2022: $13K · 2023: $6,607 · 2024: $3,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,500 · Food and Beverage: $4,619 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,500.00 |
| Food and Beverage | $4,618.61 |
| Education | $228.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $19,446.14 | 2019-2024 | Tyvaso, Orenitram, Remodulin |
| Bayer Healthcare Pharmaceuticals INC. | $15,660.12 | 2019-2024 | |
| Mylan Specialty L.P. | $12,217.51 | 2019-2024 | Yupelri, Yupelri |
| Glaxosmithkline, LLC. | $3,012.27 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,862.98 | 2019-2023 | Tezspire, Breztri, Fasenra |
| Genentech USA, INC. | $1,828.06 | 2019-2024 | Xolair |
| Actelion Pharmaceuticals US, INC. | $1,252.57 | 2019-2024 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,049.85 | 2019-2023 | |
| Grifols USA, LLC | $836.95 | 2019-2024 | Prolastin-C Liquid |
| Genzyme Corporation | $752.41 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $743.95 | 2019-2024 | Dupixent |
| Paratek Pharmaceuticals, INC. | $526.99 | 2021-2024 | Nuzyra |
| Mallinckrodt Hospital Products INC. | $435.68 | 2020-2024 | Acthar |
| Philips North America LLC | $413.76 | 2019-2023 | |
| Amgen INC. | $392.70 | 2022-2024 | Tezspire |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $368.53 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $296.42 | 2020-2024 | Glassia |
| Advanced Respiratory, INC | $269.09 | 2019-2021 | |
| Electromed, INC. | $257.65 | 2019-2024 | Smartvest |
| Novartis Pharmaceuticals Corporation | $237.69 | 2019-2024 | |
| Baxter Healthcare | $205.54 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Ani Pharmaceuticals, INC. | $166.65 | 2022-2024 | Purified Cortrophin Gel |
| Gilead Sciences, INC. | $155.70 | 2019-2022 | |
| Insmed, INC. | $135.88 | 2023-2024 | Arikayce |
| Teva Pharmaceuticals USA, INC. | $102.92 | 2021-2023 | Airduo Digihaler |
| Covis Pharma Gmbh | $95.01 | 2021-2022 | |
| Pulmonx Corporation | $89.73 | 2020-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Circassia INC. | $75.95 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $74.99 | 2022 | |
| Nabriva Therapeutics, Plc | $72.98 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $69.25 | 2024 | Winrevair |
| Mallinckrodt Enterprises LLC | $54.09 | 2019 | |
| Qiagen, LLC | $48.44 | 2020 | |
| Harmony Biosciences LLC | $43.78 | 2022 | |
| Inspire Medical Systems, INC. | $41.49 | 2023-2024 | Inspire |
| Cardiva Medical, INC. | $38.69 | 2024 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Shire North American Group INC | $38.23 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.36 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $28.87 | 2024 | Uptravi, Opsumit |
| Shionogi INC | $23.85 | 2021 | |
| Inogen, INC. | $23.23 | 2022 | |
| Abbott Laboratories | $16.62 | 2019 | |
| Chiesi USA, INC. | $15.67 | 2021 | |
| Phadia US INC. | $13.44 | 2022 | |
| Vifor Pharma, INC. | $13.39 | 2024 | Zemaira |
| Janssen Pharmaceuticals, INC | $3.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramit Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.